Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-29 @ 10:41 AM
Study NCT ID:
NCT06250894
Status:
RECRUITING
Last Update Posted:
2024-02-09
First Post:
2024-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-01
First Submit QC Date:
None
Study First Post Date:
2024-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-01
Last Update Post Date:
2024-02-09
Last Update Post Date Type:
ACTUAL